Cristina Bagacean

Title: Cristina Bagacean: Innovator in Lymphoma Classification

Introduction

Cristina Bagacean is a notable inventor based in Rouen, France. She has made significant contributions to the field of medical research, particularly in the classification of diffuse large B-cell lymphomas (DLBCLs). Her innovative work has the potential to enhance diagnostic accuracy and treatment strategies for patients suffering from this type of cancer.

Latest Patents

Cristina Bagacean holds a patent for her invention titled "Methods and kits for classifying diffuse large B-cell lymphomas (DLBCLs) into GCB-DLBCLs or into ABC-DLBCLs." This patent describes a method for classifying a DLBCL by determining the expression level of ten specific genes in a tumor tissue sample. The genes involved in this classification process include NEK6, IRF4, IGHM, LMO2, FOXP1, TNFRSF9, BCL6, TNFRSF13B, CCND2, and MYBL1. The method utilizes a Reverse Transcriptase Multiplex Ligation dependent Probe Amplification (RT-MLPA) assay, showcasing a sophisticated approach to cancer diagnostics.

Career Highlights

Throughout her career, Cristina has worked with esteemed institutions such as the National Institute of Health and Medical Research (Institut National De La Santé Et De La Recherche Médicale) and the University of Rouen (Université De Rouen). Her work in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Cristina has collaborated with notable colleagues, including Fabrice Jardin and Philippe Ruminy. These partnerships have enriched her research and expanded the impact of her innovations in the medical community.

Conclusion

Cristina Bagacean's contributions to the classification of diffuse large B-cell lymphomas represent a significant advancement in cancer research. Her innovative methods and dedication to improving patient outcomes highlight her role as a leading inventor in the medical field.